跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BACLOFEN INTRATHECAL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BACLOFEN INTRATHECAL
Authorized
STANDARD
BACLOFEN INTRATHECAL
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a8db2bbd23ab471b
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
a8db2bbd23ab471b
Drug Approval Canada Name
BACLOFEN INTRATHECAL
Product Name
BACLOFEN INTRATHECAL
Status
Marketed
Status Date
2022-12-08
Original Market Date
2022-12-08
Din
02485494
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intrathecal
Schedule
Prescription
Ahfs
12:20.12
Atc Original
M03BX01 BACLOFEN
Atc Name
m 03 bx 01
Aig Number
0113246004
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
BACLOFEN
0.05 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a8db2bbd23ab471b
Type
Standard
Back to Health Canada Approvals